Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Comprehension lacking...SGE
14
Jan 31, 2008 12:24PM
2
Jan 31, 2008 12:37PM
2
Jan 31, 2008 01:28PM
2
Jan 31, 2008 04:26PM
1
Jan 31, 2008 04:39PM

Well thought out. I can appreciate the viewpoint of protocol but am not totally sold on talks with another larger company based solely on the assumption of having a substancially greater sum of money, as based on the previous investment banking history with the company. Once this introduction took place, there were two months spent before ending discussions.

How a 420 mil share BB company at .41 buys say a Nasdaq company (in what I can only configure would be an all cash deal) and then is able to move off the BB exchange without disturbing the configuration of PDS and while finding the right synergies looks like a heck of a task in comprehension for just myself :>)

2/23/07

Beginning in October, 2006, we began and continued preliminary discussions toward possible acquisition of two different companies. We consulted a prominent investment banking firm when taking a preliminary look at a company that is on the verge of developing a revenue stream. The company on which we were focusing is beginning to market promising technology protected by an impressive patent portfolio in their market niche. We amicably ended discussions with the target company in late December.

Regards

Share
New Message
Please login to post a reply